Moxie Dwight

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Moxie Dwight's trades of Revance Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
17.06
Quantity 11,000
Value US$187,704
Transaction date
Proposed sale
Price
17.81
Quantity 23,853
Value US$424,917
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-19 2024-03-18
S Sale
74,461 -18.5%
415.28
US$92,020 		74,461 -18.5% 415.28 US$92,020
2024-03-18 2024-03-15
PrS Proposed sale
35,018
101.93
US$4,056,646 		35,018 101.93 US$4,056,646
2023-09-07 2023-09-06
PlS Planned sale
82,151 -7.0%
479.94
US$2,568,154 		82,151 -7.0% 479.94 US$2,568,154
2023-09-06 2023-09-06
PrS Proposed sale
11,000
17.06
US$187,704 		11,000 17.06 US$187,704
2023-09-07 2023-09-05
PlS Planned sale
23,853 -30.2%
17.81
US$424,920 		23,853 -30.2% 17.81 US$424,920
2023-09-05 2023-09-05
PrS Proposed sale
23,853
17.81
US$424,917 		23,853 17.81 US$424,917
2023-05-16 2023-05-15
S Sale
21,401 -23.6%
34.55
US$739,338 		21,401 -23.6% 34.55 US$739,338
2023-05-12 2023-05-12
PrS Proposed sale
22,000
33.40
US$734,800 		22,000 33.40 US$734,800
2023-03-09 2023-03-09
S Sale
18,496 -25.0%
31.59
US$584,220 		18,496 -25.0% 31.59 US$584,220
2023-03-09 2023-03-08
PrS Proposed sale
20,000
33.00
US$660,000 		20,000 33.00 US$660,000
2022-09-16 2022-09-14
PlS Planned sale
11,000 -25.8%
27.07
US$297,798 		11,000 -25.8% 27.07 US$297,798
2021-09-28 2021-09-27
PlS Planned sale
1,675 -3.4%
30.00
US$50,250 		1,675 -3.4% 30.00 US$50,250